1. Barbeau, A. 1986. Extrapyramidal Disorders, Pages 87?152,in Vinken, P. J., Bruyn, G. W., and Klawans, H. L., (eds.) Handbook of Clinical Neurology, vol. 5(49), Elsevier.
2. Hefti, F., Melamed, E., and Wurtman, R. J. 1981. The site of dopamine formation in rat striatum after L-dopa administration. J. Pharmacol. Exp. Ther. 217:189?197.
3. Hornykiewicz, O. 1974. The Mechanisms of Action of L-dopa in Parkinson's Disease. Life Sci. 15:1249?1259.
4. Mena, M. A., Murandas, V., et al. 1986. Pharmacokinetics of L-dopa in patients with Parkinson's disease. Adv. in Neurol. 45:481?486.
5. Melamed, E., Globus, M., et al. 1983. Chronic L-dopa administration decreases striatal accumulation of dopamine from exogenous L-dopa in rats with intact nigrostriatal projections. Neurology 33:905?953.